Universitätsklinikum Marburg

Marburg, Hesse 35033

2 studies enrolling now · 2 studies all time

What they study most

Leukemia Relapse, Leukemia and Lymphoma, Lymphoma Diffuse Large B-cell, Lymphoma Receiving CAR-T Therapy, Non-small Cell Lung Cancer

Studies at this site

• A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1% — Recruiting now
• Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies — Recruiting now